| __timestamp | AstraZeneca PLC | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 13324000000 | 20140000 |
| Thursday, January 1, 2015 | 11451000000 | 37173000 |
| Friday, January 1, 2016 | 9739000000 | 48616000 |
| Sunday, January 1, 2017 | 10543000000 | 108488000 |
| Monday, January 1, 2018 | 10362000000 | 244622000 |
| Tuesday, January 1, 2019 | 11848000000 | 287000000 |
| Wednesday, January 1, 2020 | 11693000000 | 354000000 |
| Friday, January 1, 2021 | 15680000000 | 186000000 |
| Saturday, January 1, 2022 | 18955000000 | 151000000 |
| Sunday, January 1, 2023 | 18025000000 | 232600000 |
| Monday, January 1, 2024 | 20532000000 | 267474000 |
Unlocking the unknown
In the ever-evolving pharmaceutical landscape, understanding the financial dynamics of industry leaders is crucial. AstraZeneca PLC, a global biopharmaceutical company, and Ionis Pharmaceuticals, Inc., a leader in RNA-targeted drug discovery, present a fascinating contrast in their Selling, General, and Administrative (SG&A) expenses over the past decade.
From 2014 to 2023, AstraZeneca's SG&A expenses have shown a steady increase, peaking in 2022 with a 42% rise from 2014. This reflects their aggressive market expansion and strategic investments. In contrast, Ionis Pharmaceuticals, with a more modest scale, saw its SG&A expenses grow by over 1,000% during the same period, highlighting its rapid growth trajectory and increased operational activities.
This comparison not only underscores the differing scales and strategies of these companies but also provides insights into their financial health and market positioning.
Comparing SG&A Expenses: Merck & Co., Inc. vs AstraZeneca PLC Trends and Insights
SG&A Efficiency Analysis: Comparing AstraZeneca PLC and Bristol-Myers Squibb Company
AstraZeneca PLC or Bio-Techne Corporation: Who Manages SG&A Costs Better?
AstraZeneca PLC vs Viking Therapeutics, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: AstraZeneca PLC vs PTC Therapeutics, Inc. Trends and Insights
Comparing SG&A Expenses: AstraZeneca PLC vs ImmunityBio, Inc. Trends and Insights
Selling, General, and Administrative Costs: AstraZeneca PLC vs Viridian Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Alnylam Pharmaceuticals, Inc. and Ionis Pharmaceuticals, Inc.
Comparing SG&A Expenses: Walgreens Boots Alliance, Inc. vs Ionis Pharmaceuticals, Inc. Trends and Insights
Ionis Pharmaceuticals, Inc. vs Apellis Pharmaceuticals, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Ionis Pharmaceuticals, Inc. and Travere Therapeutics, Inc.
Selling, General, and Administrative Costs: Ionis Pharmaceuticals, Inc. vs Xencor, Inc.